Companies in #Cardiometabolic Diseases
Found 2 companies operating in this sector.
Caspian Therapeutics
PrivateClinical-stage biopharmaceutical company spun out from Kura Oncology to develop small-molecule menin inhibitors as potentially disease-modifying therapies for diabetes and cardiometabolic diseases.
Moonwalk Biosciences
PrivateEpigenetic medicines company developing precision epigenetics reprogramming for cardiometabolic diseases. Founded with $57M launch funding.